Veliparib (ABT-888)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Veliparib (ABT-888), covering 2017-07-02 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer [Phase 1]